abstract |
The present invention provides antibodies (eg, monoclonal antibodies, human antibodies, humanized antibodies, etc.) that bind to multiple influenza strains. Such antibodies are useful, for example, for the prevention, treatment, diagnosis and / or research of influenza. Specifically, the present invention provides a binding agent that binds to influenza hemagglutinin (HA). In particular, the present invention provides certain antibodies that bind to influenza HA. In some embodiments, such antibodies are characterized by binding to specific HA epitopes and / or HA from group 1 viruses, group 2 viruses, or in some embodiments both. |